 While Johnson Johnsons JNJ , Financial Medtech sales were lower in the second quarter, revenue from hips and knee replacements was on target or above, a development that could spill over into segment competitors Stryker Corp. SYK , Financial and Zimmer Bioment Holdings Inc. ZBH , Financial, as well as robotic surgery leader Intuitive Surgical Inc. ISRG , Financial, analysts said in a Fierce Pharma article. 